Posts by ericg
Leerink may no longer be part of Silicon Valley Bank, but partnership is still on the table
SVB President Marc Cadieux said their “commitment hasn’t changed” when it comes to life science investment banking, but the bank still has a good relationship with Leerink Partners, the former SVB Securities, and its Boston-based CEO. Read More
Read MoreDeveloper pulls Somerville ‘tough tech’ mega-campus proposal— for now
Last year, Rafi Properties proposed replacing Somernova’s low-slung structures with five significantly taller buildings totaling nearly 2 million square feet, with a goal of making the property a major hub for climatetech and “tough tech.” Read More
Read MoreFish & Richardson names co-leaders of life sciences industry team
The life sciences team at Fish & Richardson provides counsel on minimizing risk, protecting innovative assets and strengthening competitive edge for its clients. Read More
Read MoreSVB president: First Citizens is ‘letting SVB be SVB’
In a conversation with the Boston Business Journal, SVB president Marc Cadieux said that First Citizens took a "patient approach" when acquiring the innovation-focused bank that collapsed last March. Read More
Read MoreOzempic, Wegovy costs could wreck employer health-care plans
Demand for the new class of weight-loss drugs has sent plan costs soaring. Read More
Read MoreSix startups combine into one dermatology biotech based in Boston and Geneva
A European biotech investor is combining six startups and supercharging their work with a $100 million investment to create new dermatology treatments. The resulting company, called Alys Pharmaceuticals Inc., is based in Boston and Geneva. Read More
Read MoreMass General Brigham doctors return to Steward’s Holy Family hospital
The state’s biggest health system pulled its doctors out of Steward’s Holy Family hospitals in Methuen and Haverhill in January, citing concerns about safety stemming from Steward’s financial troubles. Read More
Read MoreLyra Therapeutics invests in Mass. manufacturing with new HQ
The company is moving its headquarters ahead of the release of late-stage trial results for its product to treat chronic rhinosinusitis. Read More
Read MoreMGB institute is accelerating the research-to-trial process for these six projects
A year in, the institute is seeing success in its goal of shortening the timeline from research project to patients care. Read More
Read MoreSold-out MIT Sloan sports analytics conference stays true to its mission
The MIT Sloan Sports Analytics Conference (SSAC) continues to innovate and drive change in sports analytics, and this year’s event is expected to deliver an event more wide-ranging and relevant than ever, organizers say. Read More
Read More